Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 2/2011

01-02-2011 | Short Communication

Erythema elevatum diutinum in systemic lupus erythematosus

Authors: Yung Chan, Chi Chiu Mok, William Yuk Ming Tang

Published in: Rheumatology International | Issue 2/2011

Login to get access

Abstract

Erythema elevatum diutinum (EED) is a rare chronic form of leukocytoclastic vasculitis with unknown etiology. EED has been described in association with hematological malignancies, infections and a number of rheumatological diseases. We report a patient with systemic lupus erythematosus (SLE) who presented with intermittent attacks of tender nodules and plaques on the shins and ankles for 6 months. Skin biopsy confirmed the diagnosis of EED. Treatment with dapsone resulted in complete resolution of the skin lesions. EED is rarely reported in SLE, and its presentation and treatment is reviewed.
Literature
1.
Calamia KT, Balabanova M (2004) Vasculitis in systemic lupus erythematosus. Clin Dermatol 22:148–156CrossRefPubMed
2.
Crowson AN, Mihm MC Jr, Magro CM (2003) Cutaneous vasculitis: a review. J Cutan Pathol 30:161–173CrossRefPubMed
3.
Farley-Loftus R, Dadlani C, Wang N, Rosenman K, Kamino H, Prystowsky S et al (2008) Erythema elevatum diutinum. Dermatol Online J 14:13PubMed
4.
Nakajima H, Ikeda M, Yamamoto Y, Kodama H (1999) Erythema elevatum diutinum complicated by rheumatoid arthritis. J Dermatol 26:452–456PubMed
5.
Woody CM, Lane JE, Davis LS (2005) Erythema elevatum diutinum in the setting of connective tissue disease and chronic bacterial infection. J Clin Rheumatol 11:98–104CrossRefPubMed
6.
Ramos-Casals M, Nardi N, Lagrutta M, Brito-Zerón P, Bové A, Delgado G et al (2006) Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore) 85:95–104CrossRef
7.
Drenkard C, Villa AR, Reyes E, Abello M, Alarcón-Segovia D (1997) Vasculitis in systemic lupus erythematosus. Lupus 6:235–242CrossRefPubMed
8.
Cardinali C, Caproni M, Bernacchi E, Amato L, Fabbri P (2000) The spectrum of cutaneous manifestations in lupus erythematosus—the Italian experience. Lupus 9:417–423CrossRefPubMed
9.
High WA, Hoang MP, Stevens K, Cockerell CJ (2003) Late-stage nodular erythema elevatum diutinum. J Am Acad Dermatol 49:764–767CrossRefPubMed
10.
Yiannias JA, el-Azhary RA, Gibson LE (1992) Erythema elevatum diutinum: a clinical and histopathologic study of 13 patients. J Am Acad Dermatol 26:38–44CrossRefPubMed
11.
Muratori S, Carrera C, Gorani A, Alessi E (1999) Erythema elevatum diutinum and HIV infection: a report of five cases. Br J Dermatol 141:335–338CrossRefPubMed
12.
Gibson LE, Su WP (1995) Cutaneous vasculitis. Rheum Dis Clin North Am 21:1097–1113PubMed
13.
Grabbe J, Haas N, Moller A, Henz BM (2000) Erythema elevatum diutinum-evidence for disease-dependent leucocyte alterations and response to dapsone. Br J Dermatol 143:415–420CrossRefPubMed
14.
Ayoub N, Charuel JL, Diemert MC, Barete S, André M, Fermand JP et al (2004) Antineutrophil cytoplasmic antibodies of IgA class in neutrophilic dermatoses with emphasis on erythema elevatum diutinum. Arch Dermatol 140:931–936CrossRefPubMed
15.
Yamamoto T, Nakamura S, Nishioka K (2005) Erythema elevatum diutinum associated with Hashimoto’s thyroiditis and antiphospholipid antibodies. J Am Acad Dermatol 52:165–166CrossRefPubMed
16.
Bouaziz JD, Barete S, Le Pelletier F, Amoura Z, Piette JC, Francès C (2007) Cutaneous lesions of the digits in systemic lupus erythematosus: 50 cases. Lupus 16:163–167PubMed
17.
Hancox JG, Wallace CA, Sangueza OP, Graham GF (2004) Erythema elevatum diutinum associated with lupus panniculitis in a patient with discoid lesions of chronic cutaneous lupus erythematosus. J Am Acad Dermatol 50:652–653CrossRefPubMed
18.
Sachdev DS, Kharkar VD, Mahajan SA, Gupte PD (2002) Erythema elevatum diutinum. J Postgrad Med 48:310–311PubMed
Metadata
Title
Erythema elevatum diutinum in systemic lupus erythematosus
Authors
Yung Chan
Chi Chiu Mok
William Yuk Ming Tang
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 2/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1574-3

Other articles of this Issue 2/2011

Rheumatology International 2/2011 Go to the issue

Original Article

Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients

Original Article

Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients

Original Article

T-cell responses to versican in ankylosing spondylitis

Original Article

Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case–control study

Case Report

Successful switching to adalimumab in an infliximab-allergic patient with severe Behçet disease-related uveitis

Letter to the Editor

Back pain and sacroiliitis in long-standing adult celiac disease: a cross-sectional and follow-up study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits